Kenneth Krogulski - Oct 2, 2023 Form 4 Insider Report for CUMBERLAND PHARMACEUTICALS INC (CPIX)

Role
Director
Signature
Kenneth J. Krogulski by /s/ John Hamm as attorney-in-fact
Stock symbol
CPIX
Transactions as of
Oct 2, 2023
Transactions value $
$5,962
Form type
4
Date filed
10/17/2023, 05:04 PM
Previous filing
Oct 3, 2023
Next filing
Nov 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $529 +280 +0.13% $1.89 219K Oct 2, 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $518 +280 +0.13% $1.85 220K Oct 3, 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $406 +227 +0.1% $1.79 220K Oct 4, 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $518 +280 +0.13% $1.85 220K Oct 5, 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $526 +280 +0.13% $1.88 221K Oct 6, 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $577 +280 +0.13% $2.06 221K Oct 9, 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $571 +280 +0.13% $2.04 221K Oct 10, 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $571 +280 +0.13% $2.04 221K Oct 11, 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $596 +280 +0.13% $2.13 222K Oct 12, 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $580 +280 +0.13% $2.07 222K Oct 13, 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $568 +280 +0.13% $2.03 222K Oct 16, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023.